Stuart Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
Stuart Therapeutics General Information
Description
Developer of a synthesized peptide therapeutic platform intended to repair disease-damaged helical collagen in the eye. The company's method of action results in accelerated healing of epithelial cells, restoration of nerve function, and reduction of inflammation in various ophthalmic diseases, and offers a way to address indications such as dry eye disease, dry age-related macular degeneration, and glaucoma, enabling physicians to repair the damaged collagen and reduce inflammation.
Contact Information
Website
www.stuarttherapeutics.comCorporate Office
- 411 Southeast Osceola Street
- Suite 203
- Stuart, FL 34994
- United States
Corporate Office
- 411 Southeast Osceola Street
- Suite 203
- Stuart, FL 34994
- United States
Stuart Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | Completed | Clinical Trials - Phase 3 | ||||
| 2. Early Stage VC | 09-Mar-2022 | Completed | Clinical Trials - Phase 3 | |||
| 1. Early Stage VC (Series A) | 23-Mar-2021 | $11M | $11M | Completed | Clinical Trials - Phase 3 |
Stuart Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Stuart Therapeutics Comparisons
Industry
Financing
Details
Stuart Therapeutics Competitors (3)
One of Stuart Therapeutics’s 3 competitors is Regenerx, a Formerly VC-backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regenerx | Formerly VC-backed | Rockville, MD | ||||
| Azura Ophthalmics | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Aldeyra Therapeutics | Formerly VC-backed | Lexington, MA |
Stuart Therapeutics Signals
Stuart Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biobrit | Venture Capital | Minority | ||
| InFocus Capital Partners | Venture Capital | Minority | ||
| Keiretsu Forum | Angel Group | Minority | ||
| MiMo Capital (Miami) | Venture Capital | Minority | ||
| WARF Ventures | Venture Capital | Minority |
Stuart Therapeutics FAQs
-
When was Stuart Therapeutics founded?
Stuart Therapeutics was founded in 2018.
-
Where is Stuart Therapeutics headquartered?
Stuart Therapeutics is headquartered in Stuart, FL.
-
What is the size of Stuart Therapeutics?
Stuart Therapeutics has 11 total employees.
-
What industry is Stuart Therapeutics in?
Stuart Therapeutics’s primary industry is Drug Discovery.
-
Is Stuart Therapeutics a private or public company?
Stuart Therapeutics is a Private company.
-
What is Stuart Therapeutics’s current revenue?
The current revenue for Stuart Therapeutics is .
-
How much funding has Stuart Therapeutics raised over time?
Stuart Therapeutics has raised $11M.
-
Who are Stuart Therapeutics’s investors?
Biobrit, InFocus Capital Partners, Keiretsu Forum, MiMo Capital (Miami), and WARF Ventures are 5 of 6 investors who have invested in Stuart Therapeutics.
-
Who are Stuart Therapeutics’s competitors?
Regenerx, Azura Ophthalmics, and Aldeyra Therapeutics are competitors of Stuart Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process